# Kyntra Bio, Inc.: Form 8-K, filed Sep 16, 2024

- Company: [Kyntra Bio, Inc.](/companies/kynb.md) (CIK 921299)
- Form: 8-K
- Filed: 2024-09-16
- Accepted by EDGAR: Sep 16, 2024, 20:05 ET
- Period: 2024-09-12
- Accession: 0000950170-24-106818
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921299/000095017024106818/fgen-20240912.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921299/000095017024106818/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921299/000095017024106818/fgen-20240912.htm

Filed Sep 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-106818. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.